Printed from https://fyi.org.nz/request/17559-covid-19-early-treatment-options-where-are-they on April 27, 2024 07:31

COVID-19 Early Treatment Options - where are they?

Micky Turner made this Official Information request to Pharmaceutical Management Agency

The request was successful.

From: Micky Turner

Dear Pharmaceutical Management Agency,

Can you please advise if you have organized the supply of and are offering people with Covid-19 any of the following:

Fluvoxamine 89%
Budesonide 81%
Vitamin D 81%
Vitamin A 79%
Quercetin 79%
Melatonin 78%
Zinc 74%
Povidone-Iodine 71%
Sotrovimab 67%
Ivermectin 67%
Vitamin C 43%
Aspirin 21%

I have included their early treatment efficacy % beside each one. This information can be found at c19early.com

These vitamins and OTC meds should by now be being handed out to everyone with Covid 19 and their close contacts:

Vitamin D 81%
Vitamin A 79%
Quercetin 79%
Melatonin 78%
Zinc 74%
Povidone-Iodine 71%
Vitamin C 43%
Aspirin 21%

Ivermectin should also be given to people who wish to take it, so long as they have been shown the various study data and give informed consent. At worst they may get diarrhea - at best - it may save their life.

The Ministry of Health should also have enough Budesonide and inhalers for 100,000 people.

You have had 20 months to prepare for this. People are now dying. We no longer have time to play politics or who has the biggest medical degree. We need to take notice of the data and respond rapidly.

- Micky Turner

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Kia ora Micky

Thank you for your email.

Your request has been received and logged. Our reference number for your request is 2021-22-061.

As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 10 December 2021.

If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.

Ngā mihi

Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz

show quoted sections

Link to this

From: Micky Turner

Dear Web Enquiry,

Pharmac's response to this has been sent to another OIA.

Just while we are waiting for the response to be transferred to here - can you please let me know the following:

Can Pharmac purchase dietary supplements if there is supporting evidence those supplements likely reduce hospitalization and mortality?

Zinc + ionophore (Quercetin or Hinokitiol)
Vitamin D
Vitamin K

Cheers - Micky

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Kia ora Micky

Can I please confirm your below question still relates specifically to people with COVID-19?

Ngā mihi

Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz

Te Pātaka Whaioranga, Pharmac, will be closed from 25 December 2021 to 4 January 2022 inclusive.
Click here to read more about our summer holiday hours on our website.

show quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Tēnā koe Micky

 

Pharmac is continuing to evaluate potential treatments for COVID-19 as
evidence emerges.

 

We are happy to consider funding applications for COVID-19 treatments that
have not yet been considered by Pharmac.

 

[1]Records of the most recent treatments that have been considered for
funding by Pharmac have been published on our website:
[2]www.pharmac.govt.nz/about/expert-advice/advisory-groups/

 

Ngā mihi

 

 

Melody Willis ([3]she/her) | Government Services Advisor

show quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: